Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia.

In our laboratory, a two-step procedure is used for purging precursor B ALL from autologous bone marrow grafts of children in second bone marrow remission, An immunorosette depletion method with CD19 and CD22 MAbs is followed by one cycle of complement-mediated cell lysis with CD9 and CD10 MAbs, The aim of the present study was to determine if the efficacy of this procedure could be further enhanced by including CD20 and CD72 MAbs in the current protocol, Leukemia-contaminated remission bone marrow was simulated by mixing cell line cells and normal bone marrow cells, The efficacy of purging of malignant cells was determined by culturing the cells in a limiting dilution assay, The effect of including CD20 and CD72 in the immunorosette depletion was limited, In contrast, when these MAbs were added during complement-mediated cell lysis, a significant increase in depletion of tumor cells was observed, This was true when complement lysis was carried out alone (0.4 versus 3.0 log depletion for Ros cells) and when it was preceded by immunorosette depletion (2.7 versus 4.1 log depletion for Ros cells), The loss of hematopoietic progenitor cells was not greater than with the current purging protocol.